tiprankstipranks
KH Neochem Co.,Ltd. (JP:4189)
:4189
Japanese Market

KH Neochem Co.,Ltd. (4189) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4189

KH Neochem Co.,Ltd.

(4189)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
¥3,255.00
▲(31.41% Upside)
Action:ReiteratedDate:02/11/26
The score is driven primarily by solid underlying financial stability (notably conservative leverage) but tempered by mixed operating performance and historically uneven free cash flow. Technicals are supportive of an uptrend but look overextended, while valuation is a meaningful positive with a moderate P/E and strong dividend yield.
Positive Factors
Strong balance sheet
Conservative leverage (D/E ~0.26) and growing equity provide durable financial flexibility in a cyclical chemicals sector. This balance-sheet strength supports capital spending, dividend continuity and stress absorption during downturns, reducing structural refinancing and liquidity risk.
Negative Factors
Choppy revenue trend
Range-bound top line with a recent ~6% decline signals limited secular growth visibility. For a manufacturer reliant on volume and pricing, persistent revenue volatility constrains long-term capacity planning, margin recovery and sustained reinvestment programs.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet
Conservative leverage (D/E ~0.26) and growing equity provide durable financial flexibility in a cyclical chemicals sector. This balance-sheet strength supports capital spending, dividend continuity and stress absorption during downturns, reducing structural refinancing and liquidity risk.
Read all positive factors

KH Neochem Co.,Ltd. (4189) vs. iShares MSCI Japan ETF (EWJ)

KH Neochem Co.,Ltd. Business Overview & Revenue Model

Company Description
KH Neochem Co., Ltd. researches, manufactures, and sells petrochemical products in Japan and internationally. It offers a range of chemical products, such as alcohols, esters, ketones, glycol ethers, synthetic fatty acids, aldehydes, diols, hydroc...
How the Company Makes Money
KH Neochem generates revenue through the production and sale of its specialty chemical products. Its primary revenue streams include the sale of fine chemicals, which are utilized in various applications across multiple industries. The company mai...

KH Neochem Co.,Ltd. Financial Statement Overview

Summary
Balance sheet strength is the key positive (conservative and improving leverage; steady low-teens ROE). Offsetting this, income statement trends are mixed with a ~6% revenue decline in 2025 and margins well below the 2021 peak, while cash flow has been volatile despite a strong 2025 rebound and improved conversion.
Income Statement
62
Positive
Balance Sheet
74
Positive
Cash Flow
58
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue122.59B115.10B119.76B115.22B114.88B117.11B
Gross Profit26.90B24.87B25.25B21.94B24.45B32.23B
EBITDA19.04B17.58B17.17B14.60B16.75B24.19B
Net Income8.99B7.80B8.36B6.83B8.07B13.69B
Balance Sheet
Total Assets125.88B130.10B131.46B124.50B131.25B122.07B
Cash, Cash Equivalents and Short-Term Investments5.40B6.72B7.16B9.68B10.93B16.93B
Total Debt20.47B18.29B19.20B16.39B22.52B20.16B
Total Liabilities55.23B57.47B59.54B58.00B69.18B64.56B
Stockholders Equity67.80B69.68B69.09B63.74B59.35B54.92B
Cash Flow
Free Cash Flow0.009.13B-1.45B8.11B-5.27B13.36B
Operating Cash Flow0.0013.78B6.98B13.20B5.13B17.40B
Investing Cash Flow0.00-4.63B-8.90B-4.94B-10.08B-4.39B
Financing Cash Flow0.00-9.57B-645.00M-9.50B-1.08B-5.17B

KH Neochem Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2477.00
Price Trends
50DMA
2808.64
Negative
100DMA
2615.07
Positive
200DMA
2634.67
Positive
Market Momentum
MACD
-31.56
Positive
RSI
45.21
Neutral
STOCH
30.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4189, the sentiment is Neutral. The current price of 2477 is below the 20-day moving average (MA) of 2886.20, below the 50-day MA of 2808.64, and below the 200-day MA of 2634.67, indicating a neutral trend. The MACD of -31.56 indicates Positive momentum. The RSI at 45.21 is Neutral, neither overbought nor oversold. The STOCH value of 30.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4189.

KH Neochem Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥40.56B5.813.53%-3.45%30.52%
73
Outperform
¥184.72B14.034.41%3.80%-1.50%-32.46%
67
Neutral
¥102.84B11.353.88%2.61%30.29%
66
Neutral
¥751.61B10.744.79%4.21%-1.21%-27.21%
65
Neutral
¥81.43B17.820.67%10.18%-14.36%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥496.98B67.201.02%3.37%-1.94%-84.08%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4189
KH Neochem Co.,Ltd.
2,772.00
249.66
9.90%
JP:3405
Kuraray Co
1,619.00
-241.03
-12.96%
JP:4045
Toagosei Co
1,735.00
332.15
23.68%
JP:4042
Tosoh
2,362.00
276.28
13.25%
JP:4970
Toyo Gosei Co., Ltd.
10,260.00
4,572.29
80.39%
JP:5013
Yushiro Chemical Industry Co., Ltd.
2,980.00
992.08
49.91%

KH Neochem Co.,Ltd. Corporate Events

KH Neochem Lifts Dividends as Profitability Set to Improve Despite Flat Sales
Feb 6, 2026
KH Neochem reported a slight decline in performance for the fiscal year ended December 31, 2025, with net sales down 3.9% year on year to ¥115.1 billion and operating income falling 7.8% to ¥11.2 billion, while net income attributable to...
KH Neochem Cuts FY2025 Earnings Forecast on Weak Demand but Signals Profit Recovery in 2026
Jan 30, 2026
KH Neochem has cut its full-year consolidated forecast for the fiscal year ending December 31, 2025, trimming expected net sales from 127.4 billion yen to 115.0 billion yen and lowering projected operating income, ordinary income and net income by...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 11, 2026